Pharmacokinetics of multiple-dose subcutaneous flunixin meglumine in lactating dairy goats

Authors

  • J. S. Smith William R. Pritchard Veterinary Medical Teaching Hospital, University of California-Davis, Davis, CA 95616
  • J. A. Angelos Department of Medicine and Epidemiology, University of California-Davis, Davis, CA 95616
  • J. D. Rowe Department of Medicine and Epidemiology, University of California-Davis, Davis, CA 95616
  • J. L. Carlson Department of Animal Science, University of California-Davis, Davis, CA 95616
  • L. A. Tell Department of Medicine and Epidemiology, University of California-Davis, Davis, CA 95616

DOI:

https://doi.org/10.21423/aabppro20143763

Keywords:

Flunixin meglumine, NSAID, pyrexia, caprine, small ruminents

Abstract

Flunixin meglumine (FM) is a non-steroidal anti-inflammatory drug that is approved by the US Food and Drug Administration (FDA) for intravenous (IV) administration in cattle and intramuscular (IM) administration in swine for the control of pyrexia associated with respiratory disease. FM is commonly administered by the SC route in lactating goats; however, pharmacokinetic data is lacking for this administration route.

Cover image of the 47th Conference Proceedings: An image of a herd of cattle in a field at dusk. Three cows are standing in the foreground, looking adorable. Yellow background.

Downloads

Published

2014-09-18

Issue

2014

Section

AASRP Posters and Research Summaries

Most read articles by the same author(s)